Form 4: Vaxart SVP General Counsel Reports RSU Tax Withholding

Vaxart's SVP and General Counsel, Edward B. Berg, reported the withholding of 8,072 shares for tax obligations related to RSU vesting.

Summary

• Edward B. Berg, SVP, General Counsel of Vaxart, Inc. (VXRT), reported a transaction on March 18, 2026.
• The transaction involved the disposition of 8,072 shares of Vaxart common stock.
• These shares were withheld by Vaxart to satisfy income tax withholding and remittance obligations.
• The withholding was in connection with the net settlement of Restricted Stock Units (RSUs) that vested on March 18, 2026.
• The price per share for the withheld stock was $0.6346.
• Following this transaction, Edward B. Berg beneficially owns 791,786 shares of Vaxart common stock.
• The total beneficial ownership includes 70,781 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine administrative transaction related to equity compensation and does not reflect positively or negatively on the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Vaxart, Inc.'s future performance or strategic direction.

Industry Context

StockSavvy.ai notes that this Form 4 filing details a routine insider transaction, specifically the withholding of shares to cover tax obligations upon the vesting of Restricted Stock Units (RSUs). This is a common and expected practice for equity compensation and does not typically signal any material change in company operations or strategy within the biotechnology or pharmaceutical industry.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes related to existing equity compensation.

Key Dates

Recommendation

This Form 4 filing reports a routine tax withholding transaction related to RSU vesting for an insider. It does not indicate any change in the company's fundamentals or strategic direction, thus a 'hold' recommendation is appropriate as it provides no new information to alter an existing investment thesis.

Keywords

Vaxart, VXRT, Form 4, Insider Transaction, RSU, Stock Withholding, Edward B. Berg, Equity Compensation